Zobrazeno 1 - 10
of 104
pro vyhledávání: '"M. A. Khomenko"'
Publikováno v:
Вестник войск РХБ защиты, Vol 2, Iss 2, Pp 70-77 (2023)
The lecture is aimed at the improvement of the professional level of military personnel in the sphere of flamethrowerincendiary weapons of the Troops of Radiological, Chemical and Biological Protection of the Armed Forces of the Russian Federation.
Externí odkaz:
https://doaj.org/article/6d329a277e9a4d98bab948d986febe10
Autor:
A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 31, Iss 2, Pp 14-26 (2021)
Aim. A current overview of non-pharmacological and drug-based approaches to non-alcoholic fatty liver disease (NAFLD) combined with type 2 diabetes mellitus (T2D).Key points. NAFLD is associated with an increased cardiovascular risk (due to associati
Externí odkaz:
https://doaj.org/article/e0dbed8bb30c442fb21409c24beb2066
Publikováno v:
Медицинский совет, Vol 0, Iss 6, Pp 19-25 (2018)
The review focuses on the main aspects of the use of antithrombotic agents in women during pregnancy and lactation. It summarises the reasons for frequent development of gestational hypercoagulable state, which provokes some obstetric complications (
Externí odkaz:
https://doaj.org/article/847ceb0684324e4981b6ea5158c5e38b
Autor:
A. E. Bagriy, M. V. Khomenko, I. N. Tsiba, V. A. Еfremenko, E. V. Schukina, O. A. Prikolotа, A. I. Vlasenko
Publikováno v:
Медицинский вестник Юга России, Vol 0, Iss 1, Pp 4-11 (2017)
This article is devoted to contemporary approaches on statins and non-statin lipid-lowering drugs using according to authoritative Recommendations 2015-2016. Both approaches for cardiovascular risk levels estimation with life-style changes interventi
Externí odkaz:
https://doaj.org/article/abd8369f9b064b0cac7652077a356a45
Autor:
A. E. Bagriy, A. I. Dyadyk, M. V. Khomenko, I. N. Tsiba, V. A. Efremenko, E. V. Schukina, O. A. Prikolota
Publikováno v:
Атеросклероз, Vol 12, Iss 3, Pp 61-77 (2016)
This article is devoted to discussion about statin’s using in patients with atherosclerosis-associated disease, arterial hypertension, diabetes mellitus, chronic kidney disease, familial hypercholesterolaemia, rheumatoid arthritis, systemic lupus e
Externí odkaz:
https://doaj.org/article/190f0472fec1461c985c967dd8383813
Autor:
A. E. Bagriy, A. I. Dyadyk, M. V. Khomenko, I. N. Tsiba, V. A. Efremenko, E. V. Schukina, O. A. Prikolota
Publikováno v:
Атеросклероз, Vol 12, Iss 2, Pp 48-57 (2016)
This article is devoted to discussion about main aspects of current use of 3-hydroxy-3-methylglutaril CoA reductase inhibitors (statins) according last international guidelines. Statin’s base effects on lipid profile, medication regimens, side effe
Externí odkaz:
https://doaj.org/article/20a7c102a2d749ed94ca9413a39fa6ca
Autor:
A. E. Bagriy, A. I. Dyadyk, M. V. Khomenko, I. N. Tsiba, V. A. Efremenko, E. V. Shchukina, O. A. Prikolota
Publikováno v:
Атеросклероз, Vol 12, Iss 1, Pp 61-68 (2016)
This article is devoted to discussion about main aspects of current use of non-statin hypolipidemic drugs according last international guidelines (including fibrates, nicotinic acid, resins, polyunsaturated fatty acids, ezetimibe, PCSK9-inhibitors).
Externí odkaz:
https://doaj.org/article/c1f37d8e2551458aba6b479122c3028a
Publikováno v:
Journal of Manufacturing Processes. 67:611-618
A new coupled heat transfer and solidification kinetics model is developed for the optimization of microstructure during laser additive manufacturing applications. The Johnson–Mehl–Avrami–Kolmogorov equation is applied in a self-consistent mann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef3618748afd734858d6f8a17147bc19
https://doi.org/10.1016/j.jmapro.2021.05.019
https://doi.org/10.1016/j.jmapro.2021.05.019
Autor:
T. P. Osolodchenko, M. A. Khomenko
Publikováno v:
International Medical Journal. :23-26
Obesity is one of the most common non−infectious diseases worldwide among both adults and children. It is associated with the development of diseases such as metabolic syndrome, type 2 diabetes, non−alcoholic fatty liver disease, cardiovascular d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49ec49cb8e149707b9fef9e0a9f6adf9
https://doi.org/10.37436/2308-5274-2021-1-4
https://doi.org/10.37436/2308-5274-2021-1-4
Publikováno v:
Nephrology (Saint-Petersburg). 25:18-30
Diabetic nephropathy (DNP) develops in 30-40 % of patients with type 1 and 2 diabetes mellitus (DM). It is the leading cause of the end-stage renal disease (ESRD) in the world. The proportion of people with DNP in the structure of patients receiving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::551f7e0a0e52e7a251bcea8baa4e77b6
https://doi.org/10.36485/1561-6274-2021-25-1-18-30
https://doi.org/10.36485/1561-6274-2021-25-1-18-30